NCT01932801View on ClinicalTrials.gov

Harm Reduction With Pharmacotherapy (HaRP)

PHASE2CompletedINTERVENTIONAL
Enrollment

308

Participants

Timeline

Start Date

August 1, 2013

Primary Completion Date

October 11, 2018

Study Completion Date

June 30, 2019

Conditions
Alcohol Use Disorder
Interventions
DRUG

XR-NTX

OTHER

Placebo

BEHAVIORAL

HRC

Trial Locations (1)

98195

University of Washington - Harborview Medical Center, Seattle

Sponsors

Collaborators (1)

Alkermes, Inc.
All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

collaborator

Alkermes, Inc.

INDUSTRY

lead

University of Washington

OTHER

NCT01932801 - Harm Reduction With Pharmacotherapy (HaRP) | Biotech Hunter | Biotech Hunter